SCHEDULE: MasTec Insider Adjusts Forward Sale Contract

Jose Ramon Mas amends a prepaid variable forward sale contract, adjusting terms for potential future settlement in cash or MasTec shares.

Summary

• This filing is an amendment (Amendment No. 5) to a Schedule 13D, reporting changes in beneficial ownership of MasTec, Inc. common stock by Jose Ramon Mas and related entities.
• The primary purpose is to report an amendment to a prepaid variable forward sale contract entered into by Jose Ramon Mas with an unaffiliated party.
• The amendment (Fourth Amendment) adjusts the 'Floor Price' and 'Cap Price' for components of the contract, based on the volume-weighted average price (VWAP) of MasTec's common stock.
• The contract allows Jose Ramon Mas to settle the transaction in cash or MasTec shares in August or September 2027 or 2028.
• Jose Ramon Mas has pledged 340,794 shares as collateral for this contract, which was originally entered into to fund an investment in a Major League Soccer franchise.
• The total beneficial ownership reported by Jose Ramon Mas and associated entities is 6,185,090 shares, representing 7.7% of the outstanding common stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing, primarily due to the amendment of a forward sale contract which could imply future share dilution or cash outflow depending on stock performance.

Positives

• Jose Ramon Mas retains beneficial ownership and voting rights for the pledged shares during the term of the contract.
• The contract provides flexibility for settlement in either cash or MasTec shares, at Jose Ramon Mas's option.
• The filing clearly outlines the ownership structure and beneficial interests across various entities and trusts.

Negatives

• The amendment to the forward sale contract introduces adjustments to pricing terms, which could lead to future share settlement or cash payments depending on stock performance.
• A significant number of shares (340,794) are pledged as collateral, indicating potential future disposition of these shares.
• The specific Floor and Cap Prices ($246.5096/$350.5914 for Tranche 1, $157.3441/$243.0093 for Tranche 2) suggest a wide range of potential settlement values.

Risks

• Future settlement of the prepaid forward contract could result in the delivery of a substantial number of MasTec shares, potentially diluting existing shareholders.
• If the stock price is below the floor price at settlement, all pledged shares will be delivered.
• If the stock price is significantly above the cap price, the cash settlement amount could be substantial.
• The terms of the contract are complex and dependent on future stock price performance, creating uncertainty.

Future Outlook

The filing details terms of a prepaid variable forward sale contract that is set to settle in August or September of 2027 or 2028, with settlement terms dependent on the volume-weighted average price of MasTec's common stock during specified periods.

Management Comments

• Jose Ramon Mas disclaims beneficial ownership of all Shares of common stock held by the JM Trust, the JR Trust and the Family Foundation, except, in each case, to the extent of his pecuniary interest therein.

Industry Context

StockSavvy.ai notes that amendments to insider forward sale contracts are common in the energy and infrastructure sectors, often used by executives to manage personal liquidity or fund investments without immediate stock sales, but they can introduce potential future share supply dynamics.

Stakeholder Impact

• Shareholders: Potential for future share dilution if the forward contract is settled in shares, or a significant cash outflow from Jose Ramon Mas if settled in cash, depending on stock performance.
• Creditors: The pledged shares serve as collateral, providing some security for the counterparty of the forward contract.

Next Steps

• Settlement of the prepaid variable forward sale contract in August or September 2027 or 2028, either in cash or MasTec shares, at Jose Ramon Mas's option.
• Monitoring of MasTec's common stock price to determine the settlement terms of the forward contract.

Key Dates

Recommendation

The filing is an amendment to a Schedule 13D concerning a forward sale contract. While it adjusts terms and involves pledged shares, it does not present new fundamental information about MasTec's business operations or financial performance that would warrant a change in investment strategy. The potential for future share settlement is a known factor for holders of this type of contract. Therefore, a 'hold' recommendation is appropriate pending further operational or financial updates from the company.

Keywords

MasTec, Schedule 13D, Forward Sale Contract, Beneficial Ownership, Shareholder, Amendment, Collateral